{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:36:48Z","timestamp":1780087008443,"version":"3.54.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Cancer Institute, United States","award":["R01-CA221882"],"award-info":[{"award-number":["R01-CA221882"]}]},{"name":"National Cancer Institute, United States","award":["R01-CA221882"],"award-info":[{"award-number":["R01-CA221882"]}]},{"name":"National Cancer Institute, United States","award":["R01-CA221882"],"award-info":[{"award-number":["R01-CA221882"]}]},{"name":"National Cancer Institute, United States","award":["R01-CA221882"],"award-info":[{"award-number":["R01-CA221882"]}]},{"name":"National Cancer Institute, United States","award":["R01-CA221882"],"award-info":[{"award-number":["R01-CA221882"]}]},{"name":"National Cancer Institute, United States","award":["R01-CA221882"],"award-info":[{"award-number":["R01-CA221882"]}]},{"name":"National Cancer Institute, United States","award":["R01-CA221882"],"award-info":[{"award-number":["R01-CA221882"]}]},{"name":"National Cancer Institute, United States","award":["R01-CA221882"],"award-info":[{"award-number":["R01-CA221882"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00520-025-09257-4","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T06:34:17Z","timestamp":1741070057000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Aerobic exercise and aromatase inhibitor\u2013associated musculoskeletal symptoms: results of a randomized clinical trial"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1205-9950","authenticated-orcid":false,"given":"Catherine M.","family":"Bender","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Sereika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda L.","family":"Gentry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Cuglewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennie","family":"Duquette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Grove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myeong-ga","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Brufsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia J.","family":"Diego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla F.","family":"McAuliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L.","family":"Marsland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette P.","family":"Conley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk I.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"9257_CR1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1200\/JCO.2009.23.1274","volume":"28","author":"M Dowsett","year":"2010","unstructured":"Dowsett M, Cuzick J, Ingle J, Coates A, Forbes J, Bliss J, Buyse M, Baum M, Buzdar A, Colleoni M, Coombes C, Snowdon C, Gnant M, Jakesz R, Kaufmann M, Boccardo F, Godwin J, Davies C, Peto R (2010) Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. J Clin Oncol 28:509\u2013518","journal-title":"J Clin Oncol"},{"key":"9257_CR2","doi-asserted-by":"publisher","first-page":"205031212210787","DOI":"10.1177\/20503121221078722","volume":"10","author":"N Grigorian","year":"2022","unstructured":"Grigorian N, Baumrucker SJ (2022) Aromatase inhibitor-associated musculoskeletal pain: An overview of pathophysiology and treatment modalities. SAGE Open Med 10:20503121221078720","journal-title":"SAGE Open Med"},{"key":"9257_CR3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1177\/1078155211434853","volume":"18","author":"P Menas","year":"2012","unstructured":"Menas P, Merkel D, Hui W, Lawton J, Harper A, Carro G (2012) Incidence and management of arthralgias in breast cancer patients treated with aromatase inhibitors in an outpatient oncology clinic. J Oncol Pharm Pract 18:387\u2013393","journal-title":"J Oncol Pharm Pract"},{"key":"9257_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jpain.2013.11.004","volume":"15","author":"F Laroche","year":"2014","unstructured":"Laroche F, Coste J, Medkour T, Cottu PH, Pierga JY, Lotz JP, Beerblock K, Tournigand C, Decleves X, de Cremoux P, Bouhassira D, Perrot S (2014) Classification of and risk factors for estrogen deprivation pain syndromes related to aromatase inhibitor treatments in women with breast cancer: a prospective multicenter cohort study. J Pain 15:293\u2013303","journal-title":"J Pain"},{"key":"9257_CR5","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1002\/cncr.24419","volume":"115","author":"JJ Mao","year":"2009","unstructured":"Mao JJ, Stricker C, Bruner D, Xie S, Bowman MA, Farrar JT, Greene BT, DeMichele A (2009) Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors. Cancer 115:3631\u20133639","journal-title":"Cancer"},{"key":"9257_CR6","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10549-007-9774-6","volume":"111","author":"NL Henry","year":"2008","unstructured":"Henry NL, Giles JT, Ang D, Mohan M, Dadabhoy D, Robarge J, Hayden J, Lemler S, Shahverdi K, Powers P, Li L, Flockhart D, Stearns V, Hayes DF, Storniolo AM, Clauw DJ (2008) Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors. Breast Cancer Res Treat 111:365\u2013372","journal-title":"Breast Cancer Res Treat"},{"key":"9257_CR7","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1200\/JCO.2007.10.7573","volume":"25","author":"KD Crew","year":"2007","unstructured":"Crew KD, Greenlee H, Capodice J, Raptis G, Brafman L, Fuentes D, Sierra A, Hershman DL (2007) Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. J Clin Oncol 25:3877\u20133883","journal-title":"J Clin Oncol"},{"key":"9257_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.5301\/tj.5000376","volume":"101","author":"L Moscetti","year":"2015","unstructured":"Moscetti L, Agnese Fabbri M, Sperduti I, Fabrizio N, Frittelli P, Massari A, Pompei L, D\u2019Auria G, Pofi E, Ruggeri EM (2015) Adjuvant aromatase inhibitor therapy in early breast cancer: what factors lead patients to discontinue treatment? Tumori 101:469\u2013473","journal-title":"Tumori"},{"key":"9257_CR9","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.2147\/CIA.S204196","volume":"14","author":"A Nawrocka","year":"2019","unstructured":"Nawrocka A, Niestroj-Jaworska M, Mynarski A, Polechonski J (2019) Association between objectively measured physical activity and musculoskeletal disorders, and perceived work ability among adult, middle-aged and older women. Clin Interv Aging 14:1975\u20131983","journal-title":"Clin Interv Aging"},{"key":"9257_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.713700","volume":"12","author":"T Hyder","year":"2021","unstructured":"Hyder T, Marino CC, Ahmad S, Nasrazadani A, Brufsky AM (2021) Aromatase inhibitor-associated musculoskeletal syndrome: understanding mechanisms and management. Front Endocrinol (Lausanne) 12:713700","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9257_CR11","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1186\/1471-2407-11-436","volume":"11","author":"MMM Kanematsu","year":"2011","unstructured":"Kanematsu MMM, Honda J, Nagao T, Nakagawa M, Takahashi M, Tangoku A, Sasa M (2011) The time since last menstrual period is important as a clinical predictor for non-steroidal aromatase inhibitor-related arthralgia. BMC Cancer 11:436","journal-title":"BMC Cancer"},{"key":"9257_CR12","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1200\/OP.20.00113","volume":"16","author":"A Gupta","year":"2020","unstructured":"Gupta A, Henry NL, Loprinzi CL (2020) Management of aromatase inhibitor-induced musculoskeletal symptoms. JCO Oncol Pract 16:733\u2013739","journal-title":"JCO Oncol Pract"},{"key":"9257_CR13","doi-asserted-by":"crossref","unstructured":"Hall LH, King NV, Graham CD, Green SMC, Barber A, Neal RD, Foy R, Clark J, Lloyd KE, Smith SG (2022) Strategies to self-manage side-effects of adjuvant endocrine therapy among breast cancer survivors: an umbrella review of empirical evidence and clinical guidelines. J Cancer Surviv 16:1296\u20131338","DOI":"10.1007\/s11764-021-01114-7"},{"key":"9257_CR14","doi-asserted-by":"crossref","unstructured":"Roberts KE RK, Feng S, Vagenas D, Woodward NE (2020) Exercise therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer. Cochrane Database of Syst Rev 1: Art. No CD012988","DOI":"10.1002\/14651858.CD012988.pub2"},{"key":"9257_CR15","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1002\/cncr.32051","volume":"125","author":"ML Baglia","year":"2019","unstructured":"Baglia ML, Lin IH, Cartmel B, Sanft T, Ligibel J, Hershman DL, Harrigan M, Ferrucci LM, Li FY, Irwin ML (2019) Endocrine-related quality of life in a randomized trial of exercise on aromatase inhibitor-induced arthralgias in breast cancer survivors. Cancer 125:2262\u20132271","journal-title":"Cancer"},{"key":"9257_CR16","doi-asserted-by":"crossref","unstructured":"Dowling M, McDonagh B, Meade E (2017) Arthralgia in breast cancer survivors: an integrative review of endocrine therapy. Oncol Nurs Forum 44:337\u2013349","DOI":"10.1188\/17.337-349"},{"key":"9257_CR17","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1200\/JCO.2014.57.1547","volume":"33","author":"ML Irwin","year":"2015","unstructured":"Irwin ML, Cartmel B, Gross CP, Ercolano E, Li F, Yao X, Fiellin M, Capozza S, Rothbard M, Zhou Y, Harrigan M, Sanft T, Schmitz K, Neogi T, Hershman D, Ligibel J (2015) Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors. J Clin Oncol 33:1104\u20131111","journal-title":"J Clin Oncol"},{"key":"9257_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.maturitas.2018.09.005","volume":"118","author":"TH Kim","year":"2018","unstructured":"Kim TH, Kang JW, Lee TH (2018) Therapeutic options for aromatase inhibitor-associated arthralgia in breast cancer survivors: a systematic review of systematic reviews, evidence mapping, and network meta-analysis. Maturitas 118:29\u201337","journal-title":"Maturitas"},{"key":"9257_CR19","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1007\/s00520-019-05186-1","volume":"28","author":"GZJ Lu","year":"2020","unstructured":"Lu GZJ, Zhang L (2020) The efect of exercise on aromatase inhibitor-induced musculoskeletal symptoms in breast cancer survivors: a systematic review and meta-analysis. Support Care Cancer 28:1587\u20131596","journal-title":"Support Care Cancer"},{"key":"9257_CR20","doi-asserted-by":"publisher","first-page":"E26","DOI":"10.1097\/NCC.0000000000000409","volume":"40","author":"GS Yang","year":"2017","unstructured":"Yang GS, Kim HJ, Griffith KA, Zhu S, Dorsey SG, Renn CL (2017) Interventions for the treatment of aromatase inhibitor-associated arthralgia in breast cancer survivors: a systematic review and meta-analysis. Cancer Nurs 40:E26\u2013E41","journal-title":"Cancer Nurs"},{"key":"9257_CR21","doi-asserted-by":"publisher","first-page":"1222947","DOI":"10.3389\/fonc.2023.1222947","volume":"13","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Tang L, Shao J, Chen D, Jiang Y, Tang P, Wang X (2023) The effectiveness of exercise on the symptoms in breast cancer patients undergoing adjuvant treatment: an umbrella review of systematic reviews and meta-analyses. Front Oncol 13:1222947","journal-title":"Front Oncol"},{"key":"9257_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42:377\u2013381","journal-title":"J Biomed Inform"},{"key":"9257_CR23","first-page":"129","volume":"23","author":"CS Cleeland","year":"1994","unstructured":"Cleeland CS, Ryan KM (1994) Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap 23:129\u2013138","journal-title":"Ann Acad Med Singap"},{"key":"9257_CR24","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/jnci\/dji069","volume":"97","author":"A Stanton","year":"2005","unstructured":"Stanton A, Bernaards CA, Ganz PA (2005) The BCPT Symptom Scales: a measure of physical symptoms for women diagnosed with or at risk for breast cancer. J Natl Cancer Inst 97:448\u2013456","journal-title":"J Natl Cancer Inst"},{"key":"9257_CR25","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/pon.1806","volume":"20","author":"L Terhorst","year":"2011","unstructured":"Terhorst L, Blair-Belansky H, Moore PJ, Bender C (2011) Evaluation of the psychometric properties of the BCPT Symptom Checklist with a sample of breast cancer patients before and after adjuvant therapy. Psychooncology 20:961\u2013968","journal-title":"Psychooncology"},{"key":"9257_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/00005650-199303000-00006","volume":"31","author":"CA McHorney","year":"1993","unstructured":"McHorney CA, Ware JE Jr, Raczek AE (1993) The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 31:247\u201363","journal-title":"Med Care"},{"key":"9257_CR27","doi-asserted-by":"publisher","first-page":"212","DOI":"10.4103\/ijabmr.ijabmr_290_23","volume":"13","author":"A Gupta","year":"2023","unstructured":"Gupta A, Garg R, Chawla SPS, Kaur S, Goyal S (2023) Assessment of cardiovascular parameters on submaximal treadmill exercise in obese versus nonobese adults. Int J Appl Basic Med Res 13:212\u2013217","journal-title":"Int J Appl Basic Med Res"},{"key":"9257_CR28","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1249\/MSS.0000000000002117","volume":"51","author":"AV Patel","year":"2019","unstructured":"Patel AV, Friedenreich CM, Moore SC, Hayes SC, Silver JK, Campbell KL, Winters-Stone K, Gerber LH, George SM, Fulton JE, Denlinger C, Morris GS, Hue T, Schmitz KH, Matthews CE (2019) American College of Sports Medicine roundtable report on physical activity, sedentary behavior, and cancer prevention and control. Med Sci Sports Exerc 51:2391\u20132402","journal-title":"Med Sci Sports Exerc"},{"key":"9257_CR29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1249\/00005768-198205000-00012","volume":"14","author":"GA Borg","year":"1982","unstructured":"Borg GA (1982) Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14:377\u2013381","journal-title":"Med Sci Sports Exerc"},{"key":"9257_CR30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.suponc.2010.12.004","volume":"9","author":"SD Mathias","year":"2011","unstructured":"Mathias SD, Crosby RD, Qian Y, Jiang Q, Dansey R, Chung K (2011) Estimating minimally important differences for the worst pain rating of the Brief Pain Inventory-Short Form. J Support Oncol 9:72\u201378","journal-title":"J Support Oncol"},{"key":"9257_CR31","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/acr.20449","volume":"63","author":"PJ Mease","year":"2011","unstructured":"Mease PJ, Spaeth M, Clauw DJ, Arnold LM, Bradley LA, Russell IJ, Kajdasz DK, Walker DJ, Chappell AS (2011) Estimation of minimum clinically important difference for pain in fibromyalgia. Arthritis Care Res (Hoboken) 63:821\u2013826","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"9257_CR32","doi-asserted-by":"crossref","unstructured":"Bender CM, Sereika SM, Gentry AL, Cuglewski C, Duquette J, Grove G, Cummings M, Cho MG, Brufsky AM, McAuliffe P, Budway RJ, Diego EJ, Evans S, Rosenzweig MQ, Marsland AL, Conley YP, Erickson K (2024) Effects of aerobic exercise on neurocognitive function in postmenopausal women receiving endocrine therapy for breast cancer: the exercise program in cancer and cognition randomized controlled trial. Psychooncology 33:1\u201318","DOI":"10.1002\/pon.6298"},{"key":"9257_CR33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1526-4637.2009.00774.x","volume":"11","author":"TM Atkinson","year":"2010","unstructured":"Atkinson TM, Mendoza TR, Sit L, Passik S, Scher HI, Cleeland C, Basch E (2010) The brief pain inventory and its \u201cpain at its worst in the last 24 hours\u201d item: clinical trial endpoint considerations. Pain Med 11:337\u2013346","journal-title":"Pain Med"},{"key":"9257_CR34","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.jpainsymman.2016.03.010","volume":"52","author":"JRA Fields","year":"2016","unstructured":"Fields JRA, Hopkinson J, Fenlon D (2016) Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor-associated arthralgia: a feasibility study. J Pain Symptom Manage 52:548\u2013559","journal-title":"J Pain Symptom Manage"},{"key":"9257_CR35","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1634\/theoncologist.2017-0174","volume":"22","author":"KA Nyrop","year":"2017","unstructured":"Nyrop KA, Callahan LF, Cleveland RJ, Arbeeva LL, Hackney BS, Muss HB (2017) Randomized controlled trial of a home-based walking program to reduce moderate to severe aromatase inhibitor-associated arthralgia in breast cancer survivors. Oncologist 22:1238\u20131249","journal-title":"Oncologist"},{"key":"9257_CR36","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/oby.21729","volume":"25","author":"GA Thomas","year":"2017","unstructured":"Thomas GA, Cartmel B, Harrigan M, Fiellin M, Capozza S, Zhou Y, Ercolano E, Gross CP, Hershman D, Ligibel J, Schmitz K, Li FY, Sanft T, Irwin ML (2017) The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity (Silver Spring) 25:346\u2013351","journal-title":"Obesity (Silver Spring)"},{"key":"9257_CR37","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/0269215512448256","volume":"27","author":"I Cantarero-Villanueva","year":"2013","unstructured":"Cantarero-Villanueva I, Fernandez-Lao C, Caro-Moran E, Morillas-Ruiz J, Galiano-Castillo N, Diaz-Rodriguez L, Arroyo-Morales M (2013) Aquatic exercise in a chest-high pool for hormone therapy-induced arthralgia in breast cancer survivors: a pragmatic controlled trial. Clin Rehabil 27:123\u2013132","journal-title":"Clin Rehabil"},{"key":"9257_CR38","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/ecc.12155","volume":"23","author":"CA DeNysschen","year":"2014","unstructured":"DeNysschen CA, Burton H, Ademuyiwa F, Levine E, Tetewsky S, O\u2019Connor T (2014) Exercise intervention in breast cancer patients with aromatase inhibitor-associated arthralgia: a pilot study. Eur J Cancer Care (Engl) 23:493\u2013501","journal-title":"Eur J Cancer Care (Engl)"},{"key":"9257_CR39","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1002\/cncr.28756","volume":"120","author":"KM Kidwell","year":"2014","unstructured":"Kidwell KM, Harte SE, Hayes DF, Storniolo AM, Carpenter J, Flockhart DA, Stearns V, Clauw DJ, Williams DA, Henry NL (2014) Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapy. Cancer 120:2403\u20132411","journal-title":"Cancer"},{"key":"9257_CR40","first-page":"24","volume":"18","author":"ZA Marcum","year":"2010","unstructured":"Marcum ZA, Hanlon JT (2010) Recognizing the risks of chronic nonsteroidal anti-inflammatory drug use in older adults. Ann Longterm Care 18:24\u201327","journal-title":"Ann Longterm Care"},{"key":"9257_CR41","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1249\/MSS.0000000000002116","volume":"51","author":"KL Campbell","year":"2019","unstructured":"Campbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS, Zucker DS, Matthews CE, Ligibel JA, Gerber LH, Morris GS, Patel AV, Hue TF, Perna FM, Schmitz KH (2019) Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable. Medicine and Science in Sports and Exercise 51:2375\u20132390","journal-title":"Medicine and Science in Sports and Exercise"},{"key":"9257_CR42","first-page":"024","volume":"8","author":"S Kim","year":"2024","unstructured":"Kim S, Chen N, Reid P (2024) Current and future advances in practice: aromatase inhibitor-induced arthralgia. Rheumatol Adv Pract. 8:024","journal-title":"Rheumatol Adv Pract."},{"key":"9257_CR43","doi-asserted-by":"publisher","first-page":"705911","DOI":"10.3389\/fonc.2021.705911","volume":"11","author":"L Garcia-Estevez","year":"2021","unstructured":"Garcia-Estevez L, Cortes J, Perez S, Calvo I, Gallegos I, Moreno-Bueno G (2021) Obesity and breast cancer: a paradoxical and controversial relationship influenced by menopausal status. Front Oncol 11:705911","journal-title":"Front Oncol"},{"key":"9257_CR44","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s10549-010-1132-4","volume":"126","author":"DL Hershman","year":"2011","unstructured":"Hershman DL, Shao T, Kushi LH, Buono D, Tsai WY, Fehrenbacher L, Kwan M, Gomez SL, Neugut AI (2011) Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat 126:529\u2013537","journal-title":"Breast Cancer Res Treat"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09257-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09257-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09257-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T01:28:21Z","timestamp":1742002101000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09257-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["9257"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09257-4","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"2 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Boards of the University of Pittsburgh (Approval #19080223) and St. Clair Health (Approval #1712001).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants provided written informed consent upon study enrollment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Adam Brufsky, Md, PhD has the following disclosures: \u2022Consultant: Astrazeneca, Pfizer, Novartis, Lilly, Genentech\/Roche, SeaGen, Daiichi Sankyo, Merck, Agendia, Sanofi, Puma, Myriad \u2022Research Support: Agendia, Astrazeneca Kirk Erickson, PhD has the following disclosures: \u2022Member of scientific advisory boards for MedRhythms, Inc. and NeoAuvra, Inc. There are no other author conflicts to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Adam Brufsky, Md, PhD, has the following disclosures:\u2022 Consultant: Astrazeneca, Pfizer, Novartis, Lilly, Genentech\/Roche, SeaGen, Daiichi Sankyo, Merck, Agendia, Sanofi, Puma, Myriad.\u2022 Research Support: Agendia, Astrazeneca.Kirk Erickson, PhD, has the following disclosures:\u2022 Member of scientific advisory boards for MedRhythms, Inc., and NeoAuvra, Inc.There are no other author conflicts to declare.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"Clinical Trials.gov (NCT 02793921).","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trials registration"}}],"article-number":"244"}}